The overexpression of HIF-1α has been reported in numerous human cancers, including colon, brain, breast, gastric, lung, skin, ovarian, prostate, renal and pancreatic carcinoma, and is associated with a poor prognosis and failure of tumor treatment (34). Here, HIF1A is linked to exocrine pancreatic carcinoma.